Kura Oncology, Inc. (43) | Purchase Agreements (2)
- Securities Purchase Agreement dated as of November 2, 2022 by and between Kura Oncology, Inc. and Bristol-Myers Squibb Company (Filed With SEC on November 3, 2022)
- Amended and Restated Asset Purchase Agreement, dated February 12, 2015, by and between the Registrant and Araxes Pharma LLC (Filed With SEC on February 24, 2021)
